Centene (NYSE:CNC) Updates FY 2025 Earnings Guidance

Centene (NYSE:CNC) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 7.250- for the period, compared to the consensus estimate of 7.250. The company issued revenue guidance of -.

Centene Stock Performance

Centene stock traded down $2.22 during mid-day trading on Tuesday, reaching $62.60. 2,957,227 shares of the company traded hands, compared to its average volume of 4,008,076. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. Centene has a fifty-two week low of $55.03 and a fifty-two week high of $81.42. The firm’s fifty day moving average is $61.17 and its two-hundred day moving average is $67.14. The company has a market capitalization of $31.60 billion, a price-to-earnings ratio of 10.85, a price-to-earnings-growth ratio of 0.85 and a beta of 0.45.

Centene (NYSE:CNC) last announced its earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.44 by $0.36. Centene had a net margin of 1.90% and a return on equity of 13.32%. During the same quarter last year, the firm earned $0.45 EPS. On average, equities research analysts expect that Centene will post 6.82 earnings per share for the current fiscal year.

Analysts Set New Price Targets

CNC has been the subject of several recent research reports. Truist Financial reduced their target price on shares of Centene from $89.00 to $84.00 and set a “buy” rating for the company in a report on Friday, December 13th. Sanford C. Bernstein decreased their price target on shares of Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a report on Wednesday, October 30th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $75.00 target price (down from $80.00) on shares of Centene in a report on Tuesday, December 17th. Robert W. Baird upped their price objective on Centene from $66.00 to $71.00 in a research note on Tuesday. Finally, Wells Fargo & Company decreased their price objective on Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $81.31.

Insider Buying and Selling at Centene

In other Centene news, Director H James Dallas purchased 1,693 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was purchased at an average cost of $59.01 per share, with a total value of $99,903.93. Following the completion of the acquisition, the director now directly owns 1,693 shares of the company’s stock, valued at $99,903.93. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Andrew Lynn Asher purchased 17,200 shares of Centene stock in a transaction dated Wednesday, November 13th. The stock was acquired at an average cost of $58.14 per share, with a total value of $1,000,008.00. Following the completion of the acquisition, the chief financial officer now directly owns 486,847 shares in the company, valued at approximately $28,305,284.58. This trade represents a 3.66 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 45,010 shares of company stock worth $2,660,276. 0.29% of the stock is owned by corporate insiders.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.